These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 16835227

  • 21. Role of the promyelocytic leukaemia protein in cell death regulation.
    Salomoni P, Dvorkina M, Michod D.
    Cell Death Dis; 2012 Jan 12; 3(1):e247. PubMed ID: 22237204
    [Abstract] [Full Text] [Related]

  • 22. TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia.
    Chen Y, Li S, Zhou C, Li C, Ru K, Rao Q, Xing H, Tian Z, Tang K, Mi Y, Wang B, Wang M, Wang J.
    Blood; 2014 Aug 07; 124(6):936-45. PubMed ID: 24782508
    [Abstract] [Full Text] [Related]

  • 23. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.
    Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, Zhang QY, Yang HY, Huang QH, Zhou GB, Tong JH, Zhang Y, Wu JH, Hu HY, de Thé H, Chen SJ, Chen Z.
    Science; 2010 Apr 09; 328(5975):240-3. PubMed ID: 20378816
    [Abstract] [Full Text] [Related]

  • 24. PML-RARα and its phosphorylation regulate pml oligomerization and HIPK2 stability.
    Shima Y, Honma Y, Kitabayashi I.
    Cancer Res; 2013 Jul 15; 73(14):4278-88. PubMed ID: 23722549
    [Abstract] [Full Text] [Related]

  • 25. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
    Yang XW, Wang P, Liu JQ, Zhang H, Xi WD, Jia XH, Wang KK.
    Oncogene; 2014 May 22; 33(21):2700-8. PubMed ID: 23770850
    [Abstract] [Full Text] [Related]

  • 26. Triterpenoid CDDO-Im downregulates PML/RARalpha expression in acute promyelocytic leukemia cells.
    Ikeda T, Kimura F, Nakata Y, Sato K, Ogura K, Motoyoshi K, Sporn M, Kufe D.
    Cell Death Differ; 2005 May 22; 12(5):523-31. PubMed ID: 15746941
    [Abstract] [Full Text] [Related]

  • 27. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
    Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG.
    Nature; 1998 Feb 19; 391(6669):815-8. PubMed ID: 9486655
    [Abstract] [Full Text] [Related]

  • 28. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains.
    Grignani F, Testa U, Rogaia D, Ferrucci PF, Samoggia P, Pinto A, Aldinucci D, Gelmetti V, Fagioli M, Alcalay M, Seeler J, Grignani F, Nicoletti I, Peschle C, Pelicci PG.
    EMBO J; 1996 Sep 16; 15(18):4949-58. PubMed ID: 8890168
    [Abstract] [Full Text] [Related]

  • 29. The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts.
    Testa U, Grignani F, Samoggia P, Zanetti C, Riccioni R, Lo Coco F, Diverio D, Felli N, Passerini CG, Grell M, Pelicci PG, Peschle C.
    J Clin Invest; 1998 May 15; 101(10):2278-89. PubMed ID: 9593784
    [Abstract] [Full Text] [Related]

  • 30. Fusion protein of retinoic acid receptor alpha with promyelocytic leukemia protein or promyelocytic leukemia zinc finger protein recruits N-CoR-TBLR1 corepressor complex to repress transcription in vivo.
    Tomita A, Buchholz DR, Obata K, Shi YB.
    J Biol Chem; 2003 Aug 15; 278(33):30788-95. PubMed ID: 12794076
    [Abstract] [Full Text] [Related]

  • 31. PML regulates p53 stability by sequestering Mdm2 to the nucleolus.
    Bernardi R, Scaglioni PP, Bergmann S, Horn HF, Vousden KH, Pandolfi PP.
    Nat Cell Biol; 2004 Jul 15; 6(7):665-72. PubMed ID: 15195100
    [Abstract] [Full Text] [Related]

  • 32. Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways.
    Dong S, Tweardy DJ.
    Blood; 2002 Apr 15; 99(8):2637-46. PubMed ID: 11929748
    [Abstract] [Full Text] [Related]

  • 33. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology.
    Zhu G.
    Curr Pharm Biotechnol; 2013 Apr 15; 14(9):849-58. PubMed ID: 24433507
    [Abstract] [Full Text] [Related]

  • 34. The self-association coiled-coil domain of PML is sufficient for the oncogenic conversion of the retinoic acid receptor (RAR) alpha.
    Occhionorelli M, Santoro F, Pallavicini I, Gruszka A, Moretti S, Bossi D, Viale A, Shing D, Ronzoni S, Muradore I, Soncini M, Pruneri G, Rafaniello P, Viale G, Pelicci PG, Minucci S.
    Leukemia; 2011 May 15; 25(5):814-20. PubMed ID: 21331069
    [Abstract] [Full Text] [Related]

  • 35. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP.
    Oncogene; 2006 Mar 23; 25(13):1974-9. PubMed ID: 16331271
    [Abstract] [Full Text] [Related]

  • 36. Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein.
    Tsuzuki S, Towatari M, Saito H, Enver T.
    Mol Cell Biol; 2000 Sep 23; 20(17):6276-86. PubMed ID: 10938104
    [Abstract] [Full Text] [Related]

  • 37. The promyelocytic leukemia protein stimulates SUMO conjugation in yeast.
    Quimby BB, Yong-Gonzalez V, Anan T, Strunnikov AV, Dasso M.
    Oncogene; 2006 May 18; 25(21):2999-3005. PubMed ID: 16501610
    [Abstract] [Full Text] [Related]

  • 38. Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.
    Cheng GX, Zhu XH, Men XQ, Wang L, Huang QH, Jin XL, Xiong SM, Zhu J, Guo WM, Chen JQ, Xu SF, So E, Chan LC, Waxman S, Zelent A, Chen GQ, Dong S, Liu JX, Chen SJ.
    Proc Natl Acad Sci U S A; 1999 May 25; 96(11):6318-23. PubMed ID: 10339585
    [Abstract] [Full Text] [Related]

  • 39. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
    Duprez E, Lillehaug JR, Naoe T, Lanotte M.
    Oncogene; 1996 Jun 06; 12(11):2451-9. PubMed ID: 8649787
    [Abstract] [Full Text] [Related]

  • 40. The role of PML in tumor suppression.
    Salomoni P, Pandolfi PP.
    Cell; 2002 Jan 25; 108(2):165-70. PubMed ID: 11832207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.